These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 19168741)

  • 1. Impaired innate and adaptive immunity to Streptococcus pneumoniae and its effect on colonization in an infant mouse model.
    Bogaert D; Weinberger D; Thompson C; Lipsitch M; Malley R
    Infect Immun; 2009 Apr; 77(4):1613-22. PubMed ID: 19168741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against nasopharyngeal colonization by Streptococcus pneumoniae is mediated by antigen-specific CD4+ T cells.
    Trzciński K; Thompson CM; Srivastava A; Basset A; Malley R; Lipsitch M
    Infect Immun; 2008 Jun; 76(6):2678-84. PubMed ID: 18391006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Th17 responses to Streptococcus pneumoniae in humans: comparisons between adults and children in a developed and a developing country.
    Lundgren A; Bhuiyan TR; Novak D; Kaim J; Reske A; Lu YJ; Qadri F; Malley R
    Vaccine; 2012 Jun; 30(26):3897-907. PubMed ID: 22504663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T(H)17-Mediated Protection against Pneumococcal Carriage by a Whole-Cell Vaccine Is Dependent on Toll-Like Receptor 2 and Surface Lipoproteins.
    Moffitt K; Howard A; Martin S; Cheung E; Herd M; Basset A; Malley R
    Clin Vaccine Immunol; 2015 Aug; 22(8):909-16. PubMed ID: 26041040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a pneumococcal whole cell vaccine on influenza A-induced pneumococcal otitis media in infant mice.
    Manning J; Dunne EM; Wang N; Pedersen JS; Ogier JM; Burt RA; Mulholland EK; Robins-Browne RM; Malley R; Wijburg OL; Satzke C
    Vaccine; 2019 Jun; 37(26):3495-3504. PubMed ID: 31103366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal immunization with recombinant fusion protein DnaJ-ΔA146Ply enhances cross-protective immunity against Streptococcus pneumoniae infection in mice via interleukin 17A.
    Liu Y; Wang H; Zhang S; Zeng L; Xu X; Wu K; Wang W; Yin N; Song Z; Zhang X; Yin Y
    Infect Immun; 2014 Apr; 82(4):1666-75. PubMed ID: 24491576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against Streptococcus pneumoniae Invasive Pathogenesis by a Protein-Based Vaccine Is Achieved by Suppression of Nasopharyngeal Bacterial Density during Influenza A Virus Coinfection.
    Khan MN; Xu Q; Pichichero ME
    Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearance of Pneumococcal Colonization in Infants Is Delayed through Altered Macrophage Trafficking.
    Siegel SJ; Tamashiro E; Weiser JN
    PLoS Pathog; 2015 Jun; 11(6):e1005004. PubMed ID: 26107875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae.
    Xu J; Dai W; Wang Z; Chen B; Li Z; Fan X
    Clin Vaccine Immunol; 2011 Jan; 18(1):75-81. PubMed ID: 21047997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal Immunization with the Commensal
    Shekhar S; Khan R; Schenck K; Petersen FC
    Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of Naturally Acquired Immunity to
    Ramos-Sevillano E; Ercoli G; Brown JS
    Front Immunol; 2019; 10():358. PubMed ID: 30881363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of SP1683 as a pneumococcal protein that is protective against nasopharyngeal colonization.
    Moens L; Hermand P; Wellens T; Wuyts G; Derua R; Waelkens E; Ysebaert C; Godfroid F; Bossuyt X
    Hum Vaccin Immunother; 2018 May; 14(5):1234-1242. PubMed ID: 29400602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic immunization with rPotD reduces Streptococcus pneumoniae nasopharyngeal colonization in mice.
    Converso TR; Goulart C; Rodriguez D; Darrieux M; Leite LC
    Vaccine; 2017 Jan; 35(1):149-155. PubMed ID: 27884476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of Toll-like receptor 9 agonist administration in pneumococcal vaccination impacts both humoral and cellular immune responses as well as nasopharyngeal colonization in mice.
    Jensen KM; Melchjorsen J; Dagnaes-Hansen F; Sørensen UB; Laursen RR; Østergaard L; Søgaard OS; Tolstrup M
    Infect Immun; 2012 May; 80(5):1744-52. PubMed ID: 22371375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Role of
    Moffitt K; Cheung E; Manis J; Malley R
    Infect Immun; 2018 May; 86(5):. PubMed ID: 29463618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of complement in innate and adaptive immunity to pneumococcal colonization and sepsis in a murine model.
    Bogaert D; Thompson CM; Trzcinski K; Malley R; Lipsitch M
    Vaccine; 2010 Jan; 28(3):681-5. PubMed ID: 19892042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Combination of Recombinant Mycobacterium bovis BCG Strains Expressing Pneumococcal Proteins Induces Cellular and Humoral Immune Responses and Protects against Pneumococcal Colonization and Sepsis.
    Goulart C; Rodriguez D; Kanno AI; Converso TR; Lu YJ; Malley R; Leite LCC
    Clin Vaccine Immunol; 2017 Oct; 24(10):. PubMed ID: 28768668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal conjugate vaccine modulates macrophage-mediated innate immunity in pneumonia caused by Streptococcus pneumoniae following influenza.
    Mimura K; Kimura S; Kajiwara C; Nakakubo S; Schaller MA; Ishii Y; Standiford TJ; Kunkel SL; Tateda K
    Microbes Infect; 2020 Sep; 22(8):312-321. PubMed ID: 31958572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization.
    Moffitt KL; Gierahn TM; Lu YJ; Gouveia P; Alderson M; Flechtner JB; Higgins DE; Malley R
    Cell Host Microbe; 2011 Feb; 9(2):158-65. PubMed ID: 21320698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice.
    Zeng L; Liu Y; Wang H; Liao P; Song Z; Gao S; Wu Y; Zhang X; Yin Y; Xu W
    Vaccine; 2015 Feb; 33(8):1008-16. PubMed ID: 25595867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.